Condition category
Digestive System
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status
Results overdue

Plain English Summary

Background and study aims
People with Crohn's disease (a long-term condition causing inflammation of the lining of the digestive system) may experience a number of nutritional deficiencies even at times when their disease is not active. This study aims to look at the feasibility of carrying out a study to compare dietary counselling to standard written information to manage under-nutrition in people with Crohn's disease.

Who can participate?
Patients aged 18-65 with Crohn's disease in its inactive state attending outpatient appointments at Guy's and St Thomas' NHS Trust.

What the study involve?
Participants are randomly allocated to one of two groups. Both groups receive standard care in the form of written dietary information increasing portion size, meal frequency, food choice, nutrient density and food fortification. One group also receives dietary counselling tailored to provide an additional 600 kcal/d for a period of two months. At the end of the study, interviews are conducted to measure participant acceptability.

What are the possible benefits and risks of participating?
The participants may view the opportunity to receive well-established dietary counselling as a benefit of the study. The main disadvantages are the burden of participating in a study, the need to make dietary changes and the need to visit the research centre to carry out measurements on two occasions.

Where is the study run from?
Guy's and St Thomas' NHS Trust (UK)

When is the study starting and how long is it expected to run for?
February 2014 to May 2014

Who is funding the study?
King's College London (UK)

Who is the main contact?
Sheena Visram

Trial website

Contact information



Primary contact

Prof Kevin Whelan


Contact details

Diabetes and Nutritional Sciences Division
King's College London
4th Floor Franklin-Wilkins Building
150 Stamford Street
United Kingdom

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Detecting and managing undernutrition in adults with inactive Crohn's Disease: feasibility randomised comparative trial of oral nutritional support


Study hypothesis

The feasibility study will allow methodology, study design and outcome measures to be tested and a key outcome will be to measure patients' perceptions of the interventions, design and outcomes. This will provide essential information to inform the design of an adequately powered multicentre trial of oral nutritional support.

Ethics approval

NRES Committee North West Liverpool East, ref: 13/NW/0854 - approval pending

Study design

Feasibility randomised comparative trial: single centre two-armed parallel groups

Primary study design


Secondary study design

Randomised parallel trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please contact to request a patient information sheet


Nutritional support for inactive Crohn's disease


Participants will be randomised to two groups:
1. Intervention group: Receives standard care in the form of written information. In addition, they will receive dietary counselling individually tailored to increase dietary intake by 600 kcal/day over a period of two months.
2. Comparison group: Standard care only

Intervention type



Not Applicable

Drug names

Primary outcome measure

1. Recruitment rate, retention, attrition and feasibility
2. Eligibility criteria including screening for under-nutrition, study design and methodology
3. Qualitative interviews on experience of participation

Measured by Interview Acceptability Interview at at baseline and two months

Secondary outcome measures

1. Nutritional outcome measures (measured by anthropometry and food record charts)
2. Clinical Outcomes (markers of disease activity and a Stool and Symptom Diary)
3. Patient centred outcome measures (measured by questionnaires)

All completed at baseline and after two months

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Men and women aged ≥18 years
2. Diagnosis of Crohn's disease for duration of at least 6 months confirmed by standard clinical, histological and radiological criteria
3. Crohn's disease in remission as defined by Harvey Bradshaw score of < 5
4. Stable medications (see exclusion criteria), no recent surgery (see exclusion criteria) and stable symptoms for at least 2 months
5. BMI < 20 kg/m2
6. A willingness to participate
7. Individuals able to give informed consent

Participant type


Age group




Target number of participants

24 participants. Each group will aim to recruit 12 participants.

Total final enrolment


Participant exclusion criteria

1. Patients with active Crohn's disease
2. Use of the following treatments: antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs) during the preceding week
3. Currently taking steroids
4. Recent changes in dose to the following treatments: azathioprine, 6-mercaptopurine, methotrexate or α-TNF agents during the preceding 12 weeks, oral 5-aminosalicylate (5-ASA) or steroids during the preceding 4 weeks
5. Previous pan-proctocolectomy, pure perianal disease or short bowel syndrome
6. Stenotic disease
7. Sepsis or fever
8. Diabetes or coeliac disease (by serology and/or duodenal biopsy)
9. Other concomitant serious comorbidity e.g. significant hepatic, renal, endocrine, respiratory, neurological or cardiovascular disease
10. Pregnancy or lactation
11. Taking any medications with the potential to influence gastrointestinal symptoms unless taking a long-term stable dose that is unlikely to change or stop during the trial
12. Currently receiving oral nutritional supplements, enteral or parenteral nutrition, or having received dietary counselling or oral nutritional supplements, enteral or parenteral nutrition, in the previous 3 months prior to study commencement
13. Non fluent English

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

King's College London
United Kingdom

Sponsor information


King's College London (UK)

Sponsor details

c/o Keith Brennan
Room 1.8 Hodgkin Building
Guys Campus
United Kingdom

Sponsor type




Funder type


Funder name

King’s College London

Alternative name(s)

Funding Body Type

private sector organisation

Funding Body Subtype

Universities (academic only)


United Kingdom

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes

05/10/2020: The final enrolment number has been added. 07/12/2017: No publications found, verifying study status with principal investigator.